Modus Therapeutics Holding AB (OSTO:MODTX) Common Stock: kr7.30 Mil (As of Mar. 2026)


OSTO:MODTX Modus Therapeutics Holding AB OSTO:MODTX
30 GF Score
Price kr0.37
! 1 Warning Sign
View Full Analysis

What is Modus Therapeutics Holding AB Common Stock?

Modus Therapeutics Holding AB OSTO:MODTX +0.54% 30 Common Stock is kr7.30 Mil as of Mar. 2026. GuruFocus rates OSTO:MODTX with a GF Score™ of 30/100. The stock has 1 warning sign investors should review.

Modus Therapeutics Holding AB's quarterly common stock stayed the same from Sep. 2025 (kr7.30 Mil) to Dec. 2025 (kr7.30 Mil) and stayed the same from Dec. 2025 (kr7.30 Mil) to Mar. 2026 (kr7.30 Mil).

Modus Therapeutics Holding AB's annual common stock stayed the same from Dec. 2023 (kr2.16 Mil) to Dec. 2024 (kr2.16 Mil) but then increased from Dec. 2024 (kr2.16 Mil) to Dec. 2025 (kr7.30 Mil).

Modus Therapeutics Holding AB Common Stock Historical Data

* Premium members only.

The historical data trend for Modus Therapeutics Holding AB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Modus Therapeutics Holding AB Common Stock Chart

Modus Therapeutics Holding AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial 0.97 0.97 2.16 2.16 7.30

Modus Therapeutics Holding AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.16 2.16 7.30 7.30 7.30
OSTO:MODTX
30GF Score
Modus Therapeutics Holding AB OSTO:MODTX
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Modus Therapeutics Holding AB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of kr7.30 Mil mean?
Modus Therapeutics Holding AB (OSTO:MODTX) has a Common Stock of kr7.30 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Modus Therapeutics Holding AB and its competitors.
Is Modus Therapeutics Holding AB's Common Stock too high?
Modus Therapeutics Holding AB's current Common Stock is kr7.30 Mil. Overall, Modus Therapeutics Holding AB has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Modus Therapeutics Holding AB's Common Stock compare to VRTX and REGN?
Modus Therapeutics Holding AB's Common Stock of kr7.30 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Modus Therapeutics Holding AB and its competitors. Modus Therapeutics Holding AB's current Common Stock is kr7.30 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Modus Therapeutics Holding AB stock overvalued right now?
Modus Therapeutics Holding AB (OSTO:MODTX) has a current Common Stock of kr7.30 Mil. The current Common Stock is kr7.30 Mil. Modus Therapeutics Holding AB's overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Modus Therapeutics Holding AB (OSTO:MODTX), the current Common Stock is kr7.30 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Modus Therapeutics Holding AB Business Description

Address Olof Palmes gata 29 IV, Stockholm, SWE, 111 22
Modus Therapeutics Holding AB is a Swedish biotechnology company developing its patented polysaccharide, sevuparin, as a potential treatment for unmet medical needs. Its research focuses on conditions involving severe systemic inflammation, including sepsis and septic shock, severe malaria, and other related disorders, as well as anemia associated with chronic inflammatory conditions such as kidney disease.
30GF Score

Get the complete analysis for OSTO:MODTX

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.37
Price